Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 4, 2013, Pages 384-393

  Williams, Judson B ^a,b   Lopes, Renato D ^a,b   Hafley, Gail E ^a   Bruce Ferguson Jr , T ^c   Mack, Michael J ^d   Michael Gibson, C ^a,e   Harrington, Robert A ^f   Peterson, Eric D ^a,b   Smith, Peter K ^b   Mehta, Rajendra H ^a   Alexander, John H ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d Cardiopulmonary Research Science and Technology Institute   (United States)

^e PERFUSE Angiographic Laboratory   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CABG; Clopidogrel; Coronary artery bypass surgery; Dual antiplatelet therapy; Outcomes

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDIFOLIGIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; DEATH; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT OCCLUSION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OFF PUMP CORONARY SURGERY; OPERATION DURATION; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SECONDARY PREVENTION; SURGICAL TECHNIQUE; THROMBOSIS PREVENTION; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; TICLOPIDINE;

EID: 84889092091     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0904-1     Document Type: Article

References (34)

1. Lorenz RL, Schacky CV, Weber M, Meister W, Kotzur J, Reichardt B, Theisen K, Weber PC (1984) Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet 1:1261-1264
2. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S et al (1994) Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation 89:1138-1143
3. Dake M, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP (1994) Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 331:1729-1734
4. Coronary artery surgery study (CASS) (1983) A randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation 68:951-960
5. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group (1984) Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 311:1333-1339
6. Varnauskas E (1988) Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 319:332-337
7. Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG (1990) Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol 15:15-20
8. The Post Coronary Artery Bypass Graft Trial Investigators (1997) The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336:153-162
9. Chevigne M, David JL, Rigo P, Limet R (1984) Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study. Ann Thorac Surg 37:371-378
10. Limet R, David JL, Magotteaux P, Larock MP, Rigo P (1987) Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study. J Thorac Cardiovasc Surg 94:773-783
11. Stein PD, Schunemann HJ, Dalen JE, Gutterman D (2004) Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:600S-608S
12. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al (2010) Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31:2501-2555
13. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:e148-e304
14. Tricoci P, Roe MT, Mulgund J, Newby LK, Smith SC Jr, Pollack CV Jr, Fintel DJ, Cannon CP, Bhatt DL, Gibler WB, Ohman EM, Peterson ED, Harrington RA (2006) Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. Arch Intern Med 166:806-811
15. Patel JH, Stoner JA, Owora A, Mathew ST, Thadani U (2009) Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am J Cardiol 103:1687-1693
16. Alexander JH, Ferguson TB Jr, Joseph DM, Mack MJ, Wolf RK, Gibson CM, Gennevois D, Lorenz TJ, Harrington RA, Peterson ED, Lee KL, Califf RM, Kouchoukos NT (2005) The Project of Ex-vivo Vein graft Engineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J 150:643-649
17. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502
18. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S (2004) Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 110:1202-1208
19. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE et al (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706-1717
20. Kulik A, Le May MR, Voisine P, Tardif JC, Delarochelliere R, Naidoo S, Wells GA, Mesana TG, Ruel M (2010) Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial. Circulation 122:2680-2687
21. Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S (2010) Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial. J Am Coll Cardiol 56:1639-1643
22. Mannacio VA, Di Tommaso L, Antignan A, De Amicis V, Vosa C (2012) Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the cryssa (prevention of Coronary artery bypass occlusion After off-pump procedures) randomised study. Heart 98:1710-1715
23. Gurbuz AT, Zia AA, Vuran AC, Cui H, Aytac A (2006) Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg 29:190-195
24. Kim DH, Daskalakis C, Silvestry SC, Sheth MP, Lee AN, Adams S, Hohmann S, Medvedev S, Whellan DJ (2009) Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 138:1377-1384
25. Ballotta A, Saleh HZ, El Baghdady HW, Gomaa M, Belloli F, Kandil H, Balbaa Y, Bettini F, Bossone E, Menicanti L, Frigiola A, Bellucci C, Mehta RH (2007) Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg 134:132-138
26. Poston R, Gu J, Manchio J, Lee A, Brown J, Gammie J, White C, Griffith BP (2005) Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 27:584-591
27. Chin CT, Roe MT, Fox KA, Prabhakaran D, Marshall DA, Petitjean H, Lokhnygina Y, Brown E, Armstrong PW, White HD, Ohman EM (2010) Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to clarify the optimal strategy to medically manage acute coronary syndromes (TRILOGY ACS) trial. Am Heart J 160(16-22):e11
28. James S, Budaj A, Aylward P, Buck KK, Cannon CP, Cornel JH et al (2010) Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 122:1056-1067
29. Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E (2010) Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J 160:635-641
30. van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A (2010) Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 103:1116-1127
31. Held C, Bassand JP, Becker RC, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the plato trial. american college of cardiology 2010 scientific sessions atlanta, GA2010
32. Lopes RD, Williams JB, Mehta RH, Reyes EM, Hafley GE, Allen KB et al (2012) Edifoligide and long-term outcomes after coronary artery bypass grafting: Project of Ex-vivo Vein graft Engineering via Transfection IV (PREVENT IV) 5-year results. Am Heart J 164(379-386):e371
33. Williams JB, Delong ER, Peterson ED, Dokholyan RS, Ou FS, Ferguson TB Jr (2011) Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice. Circulation 123:39-45
34. Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, Pierson RN III, Griffith BP (2006) Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 131:122-130